梅奥诊所肿瘤内科副教授，毕业于威斯康星州立医学院临床医学博士(M.D.)，曾任威斯康星医学院附属医院住院医师，约翰斯霍普金斯医院资深临床研究员。

美国内科学委员会临床肿瘤学委员，美国内科学委员会委员，美国国家医师考核委员会委员。

Patrick A. Burch博士的研究主要集中于泌尿生殖系统的恶性肿瘤，发表关于内科肿瘤治疗方面学术论文44篇。罗切斯特，明尼苏达。

1．Risk factors for pancreatic neuroendocrine tumors: a clinic-based case-control study.

2. Impact of diabetes mellitus on clinical outcomes in patients undergoing surgical resection for pancreatic cancer: a retrospective, cohort study.

3. Phase II study of subcutaneous octreotide in adults with recurrent or progressive meningioma and meningeal hemangiopericytoma.

4. The prognostic value of clinical and pathologic factors in esophageal adenocarcinoma: a mayo cohort of 796 patients with extended follow-up after surgical resection.

5. Obesity adversely affects survival in pancreatic cancer patients.

6. Older versus younger patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction, and stomach: a pooled analysis of eight consecutive North Central Cancer Treatment Group (NCCTG) trials.

7. Predictors of survival from urachal cancer: a Mayo Clinic study of 49 cases.

8. A phase I clinical and pharmacokinetic study of CS-682 administered orally in advanced malignant solid tumors.

9. Phase II study of gemcitabine plus cisplatin in patients with metastatic breast cancer: a North Central Cancer Treatment Group Trial.

10. A phase IB study of the pharmacokinetics of gemcitabine and pemetrexed, when administered in rapid sequence to patients with advanced solid tumors.